On July 28, Unilever PLC rose nearly 7% in pre-market trading. The rally was driven by stronger-than-expected first-half results and an upward revision to full-year sales growth guidance.
Unilever reported H1 adjusted EPS of $1.88, up 8.05% from $1.74 in the year-ago period, with sales of $29.902 billion. Underlying sales growth reached 4.8% in H1, accelerating to 5.8% in Q2, led by robust volume growth of 5.5%. Following the strong performance, management raised full-year underlying sales growth guidance to the 4%-6% range, with H2 growth of 4%-5% expected to be driven by pricing. The earnings beat combined with upgraded guidance reinforced market confidence in Unilever's growth momentum as the company sharpens its focus on health and personal care businesses following the planned separation of its food division.
Unilever PLC operates as a global fast-moving consumer goods company across Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments, with products sold in over 190 countries under brands including Dove, Knorr, Hellmann's, and Vaseline.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
